For over two decades Roskamp Institute scientists have studied the causes and potential cures for neurological disorders such as Alzheimer’s Disease (AD), including the link between environmental agents and increased risk for AD and other brain conditions. So when...

During these challenging times, as well as taking many precautions at the Roskamp Institute to keep the laboratories and clinic functioning to serve our patients and keep the research advancing, we are paying special interest to the central nervous system aspects of...

Sarasota, Fla.— New data from a clinical trial of Alzheimer’s Disease using a drug called Nilvadipine identified by researchers at the Roskamp Institute show that patients with very mild (very early stage) Alzheimer’s disease show less cognitive decline over an...

Disappointingly, and somewhat surprisingly, two drugs aimed at halting alzheimer’s disease by reducing levels of the amyloid protein in the brain have failed in a late-stage clinical trial. The clinical trial sponsored by Washington University, called DIAN-TU,...

The Roskamp Institute scientists have a long history of research examining the causes and potential cures for neurological disorders, particularly dementias such as Alzheimer’s Disease. During several decades of research it has become abundantly clear that one of the...